← Back to Search

Biological

Autocontrolled Arm for Male Pattern Baldness

Phase 1 & 2

Waitlist Available

Led By Maryanne M. Senna, MD

Research Sponsored by Santiste Medical Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6 and month 8

Awards & highlights

Study Summary

This trial will compare the effects of two different types of platelet-rich plasma (PRP) on male patients with androgenic alopecia (AGA). One type of PRP will be activated with pulsed electrical fields (PEFA-PRP), while the other will not be activated (non-activated PRP). The trial will assess the clinical benefit of PEFA-PRP versus non-activated PRP treatment.

Eligible Conditions

Male Pattern Baldness

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6 and month 8

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6 and month 8

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 and month 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in hair density and hair regrowth

Measurement of hair regrowth

Secondary outcome measures

Clinical progression of treatment as determined by principal investigator

Clinical progression of treatment as determined by subject

Trial Design

1Treatment groups

Experimental Treatment

Group I: Autocontrolled ArmExperimental Treatment1 Intervention

The subject will be treated with both the experimental treatment and the active comparator.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Santiste Medical Inc.Lead Sponsor

Maryanne M. Senna, MDPrincipal InvestigatorLahey Hospital & Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have registered for this medical trial thus far?

"Affirmative. The information uploaded to clinicaltrials.gov suggest that this medical experiment, which was posted on May 17th 2022, is actively enrolling participants. Only 15 patients need to be recruited from one site."

Answered by AI

Is this experiment open to participants younger than 35?

"This clinical trial permits patients aged 30 to 60 years old, which is the accepted range according to its inclusion criteria."

Answered by AI

Are researchers currently recruiting participants for this research endeavor?

"Affirmative. According to clinicaltrials.gov, this medical study is currently seeking participants with enrollment having commenced on May 17th 2022 and the details last updated on May 18th 2022. The trial requires 15 individuals at one site."

Answered by AI

What eligibility criteria must individuals meet to participate in this research?

"To make the cut for this medical trial, applicants must suffer from alopecia and fall within a 30 to 60 year age bracket. No more than 15 individuals can be admitted into the experiment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Activated PRP for Treatment of Androgenetic Alopecia

2022. "Activated PRP for Treatment of Androgenetic Alopecia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05348343.

All > Androgenetic Alopecia > Alopecia